FOR THE PARENTS AND GRAND PARENTS OUT THERE. > [Original Message] > From: CDER MEDWATCH LISTSERV <[EMAIL PROTECTED]> > To: <[EMAIL PROTECTED]> > Date: 2/13/2007 5:28:46 PM > Subject: FDA MedWatch: Rotavirus, Live, Oral, Pentavalent vaccine ( RotaTeq) associated with intussusception > > MedWatch - The FDA Safety Information and Adverse Event Reporting Program > > FDA issued a Public Health Notification to inform health care providers > and consumers about 28 post-marketing reports of intussusception > following administration of Rotavirus, Live, Oral, Pentavalent vaccine > (RotaTeq). Intussusception is a serious and potentially life-threatening > condition that occurs when the intestine gets blocked or twisted. > > Because vaccine adverse events are not always reported to FDA, there may > be additional cases of intussusception following vaccination of which we > are unaware. This information is important in helping FDA and CDC assess > whether RotaTeq may be associated with an increased risk of > intussusception and, if so, to what degree. Healthcare professionals and > others are encouraged to report any cases of intussusception or other > serious events that may be associated with the use of RotaTeq to the > Vaccine Adverse Event Reporting System (VAERS). Parents should contact > their child's doctor immediately if the child has stomach pain, > vomiting, diarrhea, blood in their stool or change in their bowel > movements, as these may be signs of intussusception. > > Read the complete MedWatch 2007 Safety summary, including links to the > Notification, Label and Patient Product Information, at: > > http://www.fda.gov/medwatch/safety/2007/safety07.htm#RotaTeq > > _________________________________________________________________ > > To ensure delivery of these timely alerts to your in-box and prevent rejection of the notice by a spam filter, please add our MedWatch address, [EMAIL PROTECTED], to your address book. > > Thank you for using FDA MedWatch as a trusted source for timely safety information on drugs, devices and diagnostics regulated by the U.S. Food and Drug Administration. If you find this e-mail notification helpful, please consider telling colleagues and friends about MedWatch and this e-mail notification process. They can learn more and subscribe to the e-list at http://www.fda.gov/medwatch. > > To send a comment or question to the MedWatch program: http://www.fda.gov/medwatch/feedback.htm > > To unsubscribe from this listserve: > https://list.nih.gov/cgi-bin/wa?SUBED1=medwatch&A=1
